@Khoutam, This is my final draft of point 21. Really think that this as well as a couple of other questions, regarding recent BOD performance and statements included in there vague announcements. should possibly be put forward as lead questions. Att: Drs Wilbert van den Hoek/Dr Guido Arnout. What do 4DS believe to be their disclosure obligation to share holders, with regard to known metrics. Under ASX continual disclosure requirements (3.1 to 3.1b, guidance note 8- points 4.20 to 4.22). Requires a listed entity to disclose information concerning it, that may have a material effect on the entities value and securities. As this information is not regarded as trade secret.It is therefore reasonable to assume by ASX standards of law, that the withheld metrics are not covered by any contractual NDA agreement. Why have you not realised the metrics of the memory chip to inform the market/shareholders, as to being able to make a more informed decision regarding the value of 4DS and securities. Do you think that your position is ethical toward loyal shareholders. END
- Forums
- ASX - By Stock
- 4DS
- 4DS - Anything but Charting
4DS - Anything but Charting, page-19537
-
-
- There are more pages in this discussion • 11,179 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 4DS (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.8¢ |
Change
-0.002(2.22%) |
Mkt cap ! $155.1M |
Open | High | Low | Value | Volume |
9.0¢ | 9.1¢ | 8.8¢ | $241.7K | 2.705M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 67844 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.0¢ | 345690 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 73558 | 0.088 |
7 | 274567 | 0.087 |
6 | 586804 | 0.086 |
12 | 1022574 | 0.085 |
3 | 235000 | 0.084 |
Price($) | Vol. | No. |
---|---|---|
0.090 | 325690 | 4 |
0.091 | 206057 | 3 |
0.092 | 683892 | 3 |
0.093 | 221555 | 4 |
0.094 | 78061 | 2 |
Last trade - 14.16pm 15/07/2024 (20 minute delay) ? |
Featured News
4DS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online